• Filing Date: 2019-05-13
  • Form Type: 10-Q
  • Description: Quarterly report
v3.19.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating Expenses:    
Research and development $ 1,037,331 $ 1,943,063
General and administrative 759,253 756,151
Total Operating Expenses 1,796,584 2,699,214
Total Operating Loss (1,796,584) (2,699,214)
Other Income/(Expense):    
Gain on settlement of lawsuits 675,000
Research and development tax credit 84,072
Investment and interest income 2,255 6,169
Interest expense (334,573) (206,567)
Net Loss $ (1,369,830) $ (2,899,612)
Basic and Diluted Loss Per Common Share $ (0.00) $ (0.01)
Weighted Average Number of Common Shares Outstanding - Basic and Diluted 384,705,639 377,369,385